BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Chinese Patent Office
Cipla
Farmers Insurance
AstraZeneca
Medtronic
Accenture
Chubb
Moodys

Generated: January 23, 2018

DrugPatentWatch Database Preview

QUELICIN Drug Profile

« Back to Dashboard

Which patents cover Quelicin, and when can generic versions of Quelicin launch?

Quelicin is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in QUELICIN is succinylcholine chloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Drug patent expirations by year for QUELICIN
Pharmacology for QUELICIN
Medical Subject Heading (MeSH) Categories for QUELICIN

US Patents and Regulatory Information for QUELICIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira QUELICIN succinylcholine chloride INJECTABLE;INJECTION 008845-006 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Fish and Richardson
Chinese Patent Office
Citi
Daiichi Sankyo
Accenture
McKinsey
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot